Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
24.55 x 10 24.56 x 3
Pre-market by (Cboe BZX)
24.54 -0.80 (-3.16%) 04/01/25 [NYSE]
24.55 x 10 24.56 x 3
Pre-market 24.56 +0.02 (+0.08%) 06:03 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
24.61
Day High
25.43
Open 24.80
Previous Close 25.34 25.34
Volume 54,444,199 54,444,199
Avg Vol 58,043,055 58,043,055
Stochastic %K 20.44% 20.44%
Weighted Alpha -12.27 -12.27
5-Day Change -1.01 (-3.95%) -1.01 (-3.95%)
52-Week Range 24.48 - 31.54 24.48 - 31.54
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 139,177,504
  • Shares Outstanding, K 5,671,455
  • Annual Sales, $ 63,627 M
  • Annual Income, $ 8,031 M
  • EBIT $ 17,697 M
  • EBITDA $ 24,710 M
  • 60-Month Beta 0.67
  • Price/Sales 2.26
  • Price/Cash Flow 5.78
  • Price/Book 1.61

Options Overview Details

View History
  • Implied Volatility 28.98% ( +0.75%)
  • Historical Volatility 20.29%
  • IV Percentile 84%
  • IV Rank 74.45%
  • IV High 32.70% on 04/12/24
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.50
  • Today's Volume 142,030
  • Volume Avg (30-Day) 159,218
  • Put/Call OI Ratio 0.93
  • Today's Open Interest 3,069,993
  • Open Int (30-Day) 3,020,901

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.68
  • Number of Estimates 6
  • High Estimate 0.81
  • Low Estimate 0.62
  • Prior Year 0.82
  • Growth Rate Est. (year over year) -17.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.52 +0.08%
on 04/01/25
Period Open: 26.43
27.24 -9.91%
on 03/10/25
-1.89 (-7.15%)
since 02/28/25
3-Month
24.52 +0.08%
on 04/01/25
Period Open: 26.53
27.57 -10.99%
on 01/07/25
-1.99 (-7.50%)
since 12/31/24
52-Week
24.48 +0.25%
on 11/15/24
Period Open: 27.72
31.54 -22.19%
on 07/30/24
-3.18 (-11.47%)
since 04/01/24

Most Recent Stories

More News
Why Major Pharmaceutical Stocks Tumbled on Tuesday

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump administration's promised tariffs were set to go into effect the following day, and...

MRK : 87.12 (-2.94%)
LLY : 805.23 (-2.50%)
PFE : 24.54 (-3.16%)
Stocks Finish Higher as Magnificent Seven Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.38%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%. June E-mini S&P...

ALK : 49.04 (-0.37%)
GOOGL : 157.07 (+1.57%)
UAL : 68.20 (-1.23%)
AAPL : 223.19 (+0.48%)
PVH : 76.43 (+18.24%)
ADI : 199.18 (-1.23%)
JNJ : 153.25 (-7.59%)
MRK : 87.12 (-2.94%)
TXN : 177.99 (-0.95%)
$IUXX : 19,436.42 (+0.82%)
PFE : 24.54 (-3.16%)
ZNM25 : 111-250 (unch)
3 Ultra-High-Yield Dividend Stocks to Buy in April

March winds bring April showers. And April showers bring... a great opportunity to buy ultra-high-yield dividend stocks. I suppose they bring mayflowers too, but mayflowers won't make you a lot of money...

PFE : 24.54 (-3.16%)
ARCC : 22.29 (+0.59%)
ET : 18.73 (+0.75%)
Where Will Eli Lilly Be in 1 Year?

The company has a looming opportunity to grab the booming GLP-1 agonist market by the horns.

LLY : 805.23 (-2.50%)
PFE : 24.54 (-3.16%)
The Vanguard S&P 500 ETF Is Sinking, but This Wall Street Analyst Predicts It Will Soar 168% by 2030

The Vanguard S&P 500 ETF (NYSEMKT: VOO) tracks the performance of the S&P 500 (SNPINDEX: ^GSPC) index, which is made up of 500 companies from 11 different sectors of the economy. It's the most diversified...

NVDA : 110.15 (+1.63%)
AAPL : 223.19 (+0.48%)
BRK.A : 800,300.00 (+0.23%)
JPM : 243.66 (-0.67%)
$SPX : 5,633.07 (+0.38%)
BRK.B : 532.99 (+0.08%)
PFE : 24.54 (-3.16%)
MSFT : 382.19 (+1.81%)
TSLA : 268.46 (+3.59%)
V : 346.35 (-1.17%)
VOO : 515.80 (+0.37%)
LLY : 805.23 (-2.50%)
Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks

When a commercial aircraft encounters turbulence, a flight attendant will tell all passengers to return to their seats and buckle their seat belts. Some investors think a similar approach is appropriate...

PFE : 24.54 (-3.16%)
ET : 18.73 (+0.75%)
ARCC : 22.29 (+0.59%)
Pfizer: Value Play or Past Its Prime?

Explore the exciting world of Pfizer (NYSE: PFE) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment...

NVDA : 110.15 (+1.63%)
PFE : 24.54 (-3.16%)
Why Pfizer Is My Largest Healthcare Position

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely...

$SPX : 5,633.07 (+0.38%)
PFE : 24.54 (-3.16%)
Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

SUPN : 31.68 (-3.27%)
OGN : 14.13 (-5.10%)
ZTS : 161.91 (-1.66%)
PFE : 24.54 (-3.16%)
BMY : 59.55 (-2.36%)
ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program

/CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is...

PFE : 24.54 (-3.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 25.91
2nd Resistance Point 25.63
1st Resistance Point 25.08
Last Price 24.54
1st Support Level 24.26
2nd Support Level 23.98
3rd Support Level 23.43

See More

52-Week High 31.54
Fibonacci 61.8% 28.84
Fibonacci 50% 28.01
Fibonacci 38.2% 27.18
Last Price 24.54
52-Week Low 24.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies